Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy

Cancer is one of the leading causes of death in the industrialized world and represents a tremendous social and economic burden. As conventional therapies fail to provide a sustainable cure for most cancer patients, the emerging unique immune therapeutic approach of bacteria-mediated tumor therapy (...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncoimmunology
Autori principali: Felgner, Sebastian, Kocijancic, Dino, Frahm, Michael, Heise, Ulrike, Rohde, Manfred, Zimmermann, Kurt, Falk, Christine, Erhardt, Marc, Weiss, Siegfried
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2017
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5749626/
https://ncbi.nlm.nih.gov/pubmed/29308303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1382791
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi